Solara Active Pharma Sciences Quarterly Results for Trading Insights

SOLARA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-10 Cr
QSept 2025
Quarterly Results

Solara Active Pharma Sciences Quarterly Results Key Highlights

  • Revenue of ₹314 Cr in Sept 2025 (+12.5% vs Mar 2025, -9.5% vs Sept 2024)
  • Net Profit of ₹-10 Cr in Sept 2025 (-400.0% vs Mar 2025, -225.0% vs Sept 2024)
  • EBITDA of ₹35 Cr in Sept 2025 (-31.4% vs Mar 2025)
  • Operating Margin of 11.0% in Sept 2025 (-6.0pp vs Mar 2025)
  • Earnings Per Share of ₹-2.36 in Sept 2025 (-153.8% vs Mar 2025)

Solara Active Pharma Sciences Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 314 279 320 349 347 12.5% -9.5%
Net Profit (₹ Cr) -10 -2 11 -17 8 - -
EBITDA (₹ Cr) 35 51 58 31 62 - -
EPS (₹) -2.36 -0.93 2.46 -3.98 2.54 - -
Operating Margin (%) 11.0% 17.0% 18.0% 9.0% 18.0% - -

Solara Active Pharma Sciences Share Price Trend Around Quarterly Results

Visualize Solara Active Pharma Sciences's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Solara Active Pharma Sciences

Additional stock information and data for SOLARA

Solara Active Pharma Sciences share price today
SOLARA P/E ratio
Solara Active Pharma Sciences 52-week

Profitability Ratios

Profit Margin -3.2%
EBITDA Margin 11.1%
Operating Margin 11.0%
ROE (Annual) -3.6%

Balance Sheet Highlights

Total Assets ₹2,232 Cr
Total Equity ₹1,097 Cr
Current Assets ₹729 Cr
Current Liabilities ₹191 Cr

Cash Flow Analysis

Operating Cash Flow ₹213 Cr
Investing Cash Flow ₹-37 Cr
Financing Cash Flow ₹-181 Cr
Net Cash Flow ₹-5 Cr

Current Market Data

Current Price ₹476.10
Exchange NSE
Last Updated Apr 02, 2026

Revenue Trend (₹ Cr)

Dec 2025 349
Jun 2025 320
Mar 2025 279
Sept 2025 314

Net Profit Trend (₹ Cr)

Dec 2025 -17
Jun 2025 11
Mar 2025 -2
Sept 2025 -10

Operating Margin Trend (%)

Dec 2025 9.0%
Jun 2025 18.0%
Mar 2025 17.0%
Sept 2025 11.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Solara Active Pharma Sciences quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹430,344.72 Cr 1693.6 14,875 3,125 +10.8% - 21.0% 130.3
Divis Laboratories
Sept 2025 		₹159,214.78 Cr 5856.5 2,860 689 +7.1% - 24.1% 225.5
Torrent Pharmaceuti…
Sept 2025 		₹144,367.29 Cr 3987.2 3,219 591 +11.3% - 18.4% 227.3
Lupin
Sept 2025 		₹107,238.09 Cr 2274.5 6,921 1,485 +23.2% - 21.5% 70.3
Dr Reddys Laborator…
Sept 2025 		₹106,974.57 Cr 1217.3 9,135 1,337 +1.1% - 14.6% 75.2
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores